Matthew Kalnik

2011 - Biota Pharmaceuticals

In 2011, Matthew Kalnik earned a total compensation of $692.8K as Former Sr. Vice President, Strategic Planning & Business Operations at Biota Pharmaceuticals, a 18% decrease compared to previous year.

Compensation breakdown

Bonus$18,374
Option Awards$162,000
Salary$316,131
Stock Awards$174,300
Other$21,988
Total$692,793

Kalnik received $316.1K in salary, accounting for 46% of the total pay in 2011.

Kalnik also received $18.4K in bonus, $162K in option awards, $174.3K in stock awards and $22K in other compensation.

Rankings

In 2011, Matthew Kalnik's compensation ranked 6,961st out of 10,747 executives tracked by ExecPay. In other words, Kalnik earned more than 35.2% of executives.

ClassificationRankingPercentile
All
6,961
out of 10,747
35th
Division
Manufacturing
2,536
out of 3,960
36th
Major group
Chemicals And Allied Products
606
out of 1,033
41st
Industry group
Drugs
410
out of 781
48th
Industry
Biological Products, Except Diagnostic Substances
65
out of 157
59th
Source: SEC filing on October 1, 2013.

Kalnik's colleagues

We found two more compensation records of executives who worked with Matthew Kalnik at Biota Pharmaceuticals in 2011.

2011

Raafat Fahim

Biota Pharmaceuticals

Chief Executive Officer

2011

Paul Kessler

Biota Pharmaceuticals

Chief Medical Officer

News

You may also like